Transcatheter closure of congenital ventricular septal defects using the Amplatzer Duct Occluder II device: preliminary data from a Tunisian monocentric study

##plugins.themes.academic_pro.article.sidebar##

Published May 15, 2022
Download
pdf
Vol. 100 No. 6 (2022): Issue Juin 2022

##plugins.themes.academic_pro.article.main##

Mehdi Slim
Sameh Ben Farhat
Sami Ben Ouannes
Raoudha Chrigui
Faten Yahia
Houceme Thabet
Houda Ghardallou
Rym Gribaa
Aymen ElHraiech
Elies Neffati

Abstract

Introduction: Percutaneous closure of congenital ventricular septal defects (VSDs) represents a promising alternative to surgery with lower rate of
complications and shorter hospital stay. Its main limitation is the choice of the appropriate device for each type of defect.

Aim: To report the experience of the service of cardiology (Sahloul hospital, Sousse, Tunisia) in percutaneous closure of congenital VSDs with Amplatzer
Duct Occluder II (ADOII).

Methods: This was a retrospective, monocentric study, conducted from January 2013 to December 2017. The study included patients treated by
percutaneous closure of congenital VSDs with the ADOII device.

Results: Twelve patients (6 boys; 6 girls) were included. The mean±SD of patients’ age and weight were 65±41 months and 23±10 kg, respectively. VSDs were
peri-membranous (n=9) and muscular (n=3), and defects were restrictive (n=11) and non-restrictive (n=1). The mean (minimum-maximum) size of VSDs was 4.72
(3-6) mm. Eleven ADOII prostheses were successfully implanted. One failure procedure was noted with migration of the device into the pulmonary artery. A second
child with perimembranous defect developed transient atrioventricular block. No deaths occurred.

Conclusion.: The present early experience shows that percutaneous closure with ADOII device of perimembranous and trabecular VSDs is safe and effective.


##plugins.themes.academic_pro.article.details##

References

  1. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988 Aug;78(2):361–8. DOI: 10.1161/01.cir.78.2.361
  2. Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children. J Am Coll Cardiol. 1999 Apr;33(5):1395– 9. DOI: 10.1016/s0735-1097(99)00011-x
  3. Janorkar S, Goh T, Wilkinson J. Transcatheter closure of ventricular septal defects using the Rashkind device: initial experience. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 1999 Jan;46(1):43–8. DOI: 10.1002/(SICI)1522- 726X(199901)46:1<43::AID-CCD12>3.0.CO;2-T
  4. Sideris EB, Walsh KP, Haddad JL, Chen CR, Ren SG, Kulkarni H. Occlusion of congenital ventricular septal defects by the buttoned device. “Buttoned device” Clinical Trials International Register. Heart Br Card Soc. 1997 Mar;77(3):276–9. DOI: 10.1136/hrt.77.3.276
  5. Bridges ND, Perry SB, Keane JF, Goldstein SAN, Mandell V, Mayer JE, et al. Preoperative Transcatheter Closure of Congenital Muscular Ventricular Septal Defects. N Engl J Med. 1991 May 9;324(19):1312–7. DOI: 10.1056/NEJM199105093241903
  6. Knauth AL, Lock JE, Perry SB, McElhinney DB, Gauvreau K, Landzberg MJ, et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation. 2004 Aug 3;110(5):501–7. DOI: 10.1161/01. CIR.0000137116.12176.A6
  7. Carminati M, Butera G, Chessa M, De Giovanni J, Fisher G, Gewillig M, et al. Transcatheter closure of congenital ventricular septal defects: results of the European Registry. Eur Heart J. 2007 Oct;28(19):2361–8. DOI: 10.1093/eurheartj/ehm314
  8. Butera G, Chessa M, Carminati M. Percutaneous closure of ventricular septal defects. State of the art. J Cardiovasc Med Hagerstown Md. 2007 Jan;8(1):39–45. DOI: 10.2459/01. JCM.0000247434.59451.d7
  9. Carminati M, Butera G, Chessa M, Drago M, Negura D, Piazza L. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders. Am J Cardiol. 2005 Dec 19;96(12A):52L-58L. DOI: 10.1016/j.amjcard.2005.09.068
  10. Butera G, Piazza L, Saracino A, Chessa M, Carminati M. Transcatheter Closure of Membranous Ventricular Septal Defects-Old Problems and New Solutions. Interv Cardiol Clin. 2013 Jan;2(1):85–91. DOI: 10.1016/j.iccl.2012.09.003
  11. Yang L, Tai B-C, Khin LW, Quek SC. A systematic review on the efficacy and safety of transcatheter device closure of ventricular septal defects (VSD). J Intervent Cardiol. 2014 Jun;27(3):260– 72. DOI: 10.1111/joic.12121
  12. Santhanam H, Yang L, Chen Z, Tai B-C, Rajgor DD, Quek S-C. A meta-analysis of transcatheter device closure of perimembranous ventricular septal defect. Int J Cardiol. 2018 01;254:75–83. DOI: 10.1016/j.ijcard.2017.12.011
  13. . Cinteză EE, Butera G. Complex ventricular septal defects. Update on percutaneous closure. Romanian J Morphol Embryol Rev Roum Morphol Embryol. 2016;57(4):1195–205. DOI: 10.1016/S1885-5857(06)60177-1
  14. Narin N, Baykan A, Pamukcu O, Argun M, Ozyurt A, Mese T, et al. ADO II in Percutaneous VSD Closure in Pediatric Patients. J Intervent Cardiol. 2015 Oct;28(5):479–84. DOI: 10.1111/joic.12222
  15. Fischer G, Apostolopoulou SC, Rammos S, Schneider MB, Bjørnstad PG, Kramer HH. The Amplatzer Membranous VSD Occluder and the vulnerability of the atrioventricular conduction system. Cardiol Young. 2007 Oct;17(5):499–504. DOI: 10.1017/S1047951107000984
  16. Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee K-J. Complete heart block associated with device closure of perimembranous ventricular septal defects. J Thorac Cardiovasc Surg. 2008 Nov;136(5):1223–8. • DOI: 10.1016/j.jtcvs.2008.02.037
  17. Bentham JR, Gujral A, Adwani S, Archer N, Wilson N. Does the technique of interventional closure of perimembranous ventricular septal defect reduce the incidence of heart block? Cardiol Young. 2011 Jun;21(3):271–80. DOI: 10.1017/S1047951110002039
  18. Vijayalakshmi IB, Narasimhan C, Singh B, Manjunath CN. Treatment of congenital non-ductal shunt lesions with the amplatzer duct occluder II. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2017 May;89(6):E185–93. DOI: 10.1002/ccd.25250
  19. Ovaert C, Kammache I, Bonello B, Habib G, Fraisse A. Occlusion percutanée des communications intercardiaques. Arch Cardiovasc Dis Suppl. 2011 Jun 1;3(2):154–62. DOI: 10.1016/ S1878-6480(11)70346-9
  20. El Tahlawi M, Kammache I, Fraisse A. Ventricular septal defect closure in a small children with the Amplatzer Duct Occluder II. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2011 Feb 1;77(2):268–71. DOI: 10.1002/ccd.22723
  21. Tan CA, Levi DS, Moore JW. Percutaneous closure of perimembranous ventricular septal defect associated with a ventricular septal aneurysm using the Amplatzer ductal occluder. Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv. 2005 Nov;66(3):427–31. DOI: 10.1002/ccd.20499
  22. Dilawar M, Numan M, El-Sisi A, Gendi SM, Ahmad Z. Percutaneous closure of ventricular septal defect associated with tunnel-shaped aneurysm using the Amplatzer duct occluder. Pediatr Cardiol. 2008 Mar;29(2):366–70. DOI: 10.1007/s00246-007-9092-0
  23. Kanaan M, Ewert P, Berger F, Assa S, Schubert S. Follow-up of patients with interventional closure of ventricular septal defects with Amplatzer Duct Occluder II. Pediatr Cardiol. 2015 Feb;36(2):379–85. DOI: 10.1007/s00246-014-1017-0